uniQure N.V.

US$21.70As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:QUREHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 12.29%
Div yield —
ROE (88.99%)
Biotechnology
Beta (5Y) 1.13
PE TTM —
TSR TTM (67.94%)
Mkt cap US$1.522B
ROIC (159.27%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$24
10.38%
(64.11%)
Hold 7|9|8|11|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.29
0.29
0.30
0.32
14.96%
7.81%
4.95%
9.86%
Revenue$M
77.74
76.24
77.34
78.15
7.46%
2.13%
4.36%
5.04%
Peers (US$1.522B)
Cap (US$)
PE
875.4M
43.62x
Capital
TTM
5Y
10Y
Leveragex
0.067
0.496
0.466
EBIT/Intx
0.969
0.379
0.324
Own earn%
(201.11)
62.76
63.70
Sh yield%
36.12
28.33
28.86
Owners
Insiders/Inst%
4.56
46.62
Short interest%
5.39
SBC / revenue%
3.71
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
25–30
$1 testx
—
Incr. ROIC%
0